A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma

Shan-Shan Jiang, Yan Tang, Yaojun Zhang, +13

Oncotarget

IL-17A Promotes Immune Cell Recruitment in Human Esophageal Cancers and the Infiltrating Dendritic Cells Represent a Positive Prognostic Marker for Patient Survival

Lin Lü, Ke Pan, Haixia Zheng, +10

Journal of Immunotherapy

Positive Prognostic MarkerImmunologyImmune RegulationPathologyImmunoediting +25

Interleukin-37 Mediates the Antitumor Activity in Hepatocellular Carcinoma: Role for CD57+ NK Cells

Jing-Jing Zhao, Qiu-Zhong Pan, Ke Pan, +8

Scientific Reports

Clinical Activity of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Post-Mastectomy Triple-Negative Breast Cancer

Ke Pan, Xun-Xing Guan, Yong-Qiang Li, +11

Clinical Cancer Research

IL-17 induces antitumor immunity by promoting beneficial neutrophil recruitment and activation in esophageal squamous cell carcinoma

Chang-Long Chen, Ying Wang, Chun-yu Huang, +10

OncoImmunology

ImmunologyImmune RegulationPathologyImmunoeditingImmunologic Mechanism +22

Tumor cells PD-L1 expression as a favorable prognosis factor in nasopharyngeal carcinoma patients with pre-existing intratumor-infiltrating lymphocytes

Qian Zhu, Mu-Yan Cai, Chang-Long Chen, +7

OncoImmunology

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma

Shan-Shan Jiang, De-Sheng Weng, Qi-Jing Wang, +8

Journal of Translational Medicine

The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma

Shan-Shan Jiang, De-Sheng Weng, Long Jiang, +11

Journal of Cancer

The Efficacy of Cytokine-Induced Killer Cell Infusion as an Adjuvant Therapy for Postoperative Hepatocellular Carcinoma Patients

Ke Pan, Yong-Qiang Li, Wei Wang, +16

Annals of Surgical Oncology

Radiation OncologyHepatologyMedicineImmunologyLiver Cancer +6

Annexin A3 as a Potential Target for Immunotherapy of Liver Cancer Stem-Like Cells

Qiu-Zhong Pan, Ke Pan, Qi-Jing Wang, +13

Stem Cells

Cancer ImmunosurveillanceHcc SamplesAnnexin A3ImmunologyImmune Checkpoint Inhibitor +11